Corium ’s Corplex Donepezil demonstrates positive outcome in pilot BE trial

US-based Corium International has reported positive preliminary results from a pilot bioequivalence (BE) clinical trial of Corplex Donepezil in healthy subjects.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news